Alzheimer's Disease

In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administration approved aducanumab, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. (Biogen via AP)

U.S. approves much-debated Alzheimer’s drug aducanumab panned by experts

Drug from Biogen deemed “reasonably likely” to benefit Alzheimer’s patients

 

Christmas can be a tough time for those suffering from dementia. (File photo)

Alzheimer’s Society helping Okanagan residents prepare for the holidays

Webinars look at new challenges COVID-19 brings and how that affects those with dementia

 

Dick Fairbanks didn’t see his wife Pat for six months while she was in a carehome during COVID-19 before he died Oct. 6, 2020. (Contributed)

Care home restrictions break Okanagan couple’s heart

Dick and Pat Fairbanks hadn’t shared a loving embrace for more than six months before it was too late